En virtud de la autoridad que me confieren como Presidente la Constitución y las leyes de los Estados Unidos de América, por la presente se ordena:

Sección 1. Propósito . La expectativa de vida en los Estados Unidos es muy inferior a la de otros países desarrollados: antes de la COVID-19, la expectativa de vida en los Estados Unidos era de 78,8 años en promedio, mientras que en países comparables era   de 82,6 años en promedio. Esto equivale a 1.250 millones de años de vida menos para la población de los Estados Unidos. Seis de cada diez estadounidenses padecen al menos una enfermedad crónica y cuatro de cada diez padecen dos o más enfermedades crónicas. Se estima que uno de cada cinco adultos en los Estados Unidos padece una enfermedad mental.

Estas realidades se vuelven aún más dolorosas cuando se comparan con las de otros países del mundo. En 204 países y territorios, Estados Unidos tuvo la tasa de incidencia de cáncer estandarizada por edad más alta en 2021, casi el doble de la siguiente tasa más alta. Además, entre 1990 y 2021, Estados Unidos experimentó un aumento del 88 por ciento en el cáncer, el mayor aumento porcentual de todos los países evaluados. En 2021, el asma fue más del doble de común en Estados Unidos que en la mayor parte de Europa, Asia o África. Los trastornos del espectro autista tuvieron la prevalencia más alta en los países de altos ingresos, incluido Estados Unidos, en 2021. De manera similar, las enfermedades autoinmunes como la enfermedad inflamatoria intestinal, la psoriasis y la esclerosis múltiple se diagnostican con mayor frecuencia en áreas de altos ingresos como Europa y América del Norte. En general, los datos de comparación global demuestran que la salud de los estadounidenses sigue una trayectoria alarmante que requiere una acción inmediata.

Esta preocupación se aplica con urgencia a los niños de Estados Unidos. En 2022, se estima que 30 millones de niños (40,7 por ciento) tenían al menos una afección de salud, como alergias, asma o una enfermedad autoinmune. El trastorno del espectro autista afecta ahora a 1 de cada 36 niños en los Estados Unidos, un aumento asombroso respecto de las tasas de 1 a 4 de cada 10.000 niños identificados con la afección durante la década de 1980. El 18 por ciento de los adolescentes tardíos y los adultos jóvenes tienen enfermedad del hígado graso, cerca del 30 por ciento de los adolescentes son prediabéticos y más del 40 por ciento de los adolescentes tienen sobrepeso u obesidad.

Estas cargas sanitarias han seguido aumentando junto con el aumento de la prescripción de medicamentos. Por ejemplo, en el caso del trastorno por déficit de atención e hiperactividad, más de 3,4 millones de niños toman actualmente medicación para el trastorno (frente a los 3,2 millones de niños que lo tomaban en 2019-2020) y el número de niños a los que se les diagnostica la afección sigue aumentando.  

This poses a dire threat to the American people and our way of life.  Seventy-seven percent of young adults do not qualify for the military based in large part on their health scores.  Ninety percent of the Nation’s $4.5 trillion in annual healthcare expenditures is for people with chronic and mental health conditions.  In short, Americans of all ages are becoming sicker, beset by illnesses that our medical system is not addressing effectively.  These trends harm us, our economy, and our security.

To fully address the growing health crisis in America, we must re-direct our national focus, in the public and private sectors, toward understanding and drastically lowering chronic disease rates and ending childhood chronic disease.  This includes fresh thinking on nutrition, physical activity, healthy lifestyles, over-reliance on medication and treatments, the effects of new technological habits, environmental impacts, and food and drug quality and safety.  We must restore the integrity of the scientific process by protecting expert recommendations from inappropriate influence and increasing transparency regarding existing data.  We must ensure our healthcare system promotes health rather than just managing disease.

Sec. 2.  Policy.  It shall be the policy of the Federal Government to aggressively combat the critical health challenges facing our citizens, including the rising rates of mental health disorders, obesity, diabetes, and other chronic diseases.  To do so, executive departments and agencies (agencies) that address health or healthcare must focus on reversing chronic disease.  Under this policy:

(a)  all federally funded health research should empower Americans through transparency and open-source data, and should avoid or eliminate conflicts of interest that skew outcomes and perpetuate distrust;

(b)  the National Institutes of Health and other health-related research funded by the Federal Government should prioritize gold-standard research on the root causes of why Americans are getting sick;

(c)  agencies shall work with farmers to ensure that United States food is the healthiest, most abundant, and most affordable in the world; and

(d)  agencies shall ensure the availability of expanded treatment options and the flexibility for health insurance coverage to provide benefits that support beneficial lifestyle changes and disease prevention.

Sec. 3.  Establishment and Composition of the President’s Make America Healthy Again Commission.  (a)  There is hereby established the President’s Make America Healthy Again Commission (Commission), chaired by the Secretary of Health and Human Services (Chair), with the Assistant to the President for Domestic Policy serving as Executive Director (Executive Director).

(b)  In addition to the Chair and the Executive Director, the Commission shall include the following officials, or their designees:

(i)     the Secretary of Agriculture;

(ii)    the Secretary of Housing and Urban Development;

(iii)   the Secretary of Education;

(iv)    the Secretary of Veterans Affairs;

(v)     the Administrator of the Environmental Protection Agency;

(vi)    the Director of the Office of Management and Budget;

(vii)   the Assistant to the President and Deputy Chief of Staff for Policy;

(viii)  the Director of the National Economic Council;

(ix)    the Chairman of the Council of Economic Advisers;

(x)     the Director of the Office of Science and Technology Policy;

(xi)    the Commissioner of Food and Drugs;

(xii)   the Director for the Centers for Disease Control and Prevention;

(xiii)  the Director of the National Institutes of Health; and

(xiv)   other members of my Administration invited to participate, at the discretion of the Chair and the Executive Director.

Sec. 4.  Fighting Childhood Chronic Disease.  The initial mission of the Commission shall be to advise and assist the President on how best to exercise his authority to address the childhood chronic disease crisis.  Therefore, the Commission shall:

(a)  study the scope of the childhood chronic disease crisis and any potential contributing causes, including the American diet, absorption of toxic material, medical treatments, lifestyle, environmental factors, Government policies, food production techniques, electromagnetic radiation, and corporate influence or cronyism;  

(b)  advise and assist the President on informing the American people regarding the childhood chronic disease crisis, using transparent and clear facts; and

(c)  provide to the President Government-wide recommendations on policy and strategy related to addressing the identified contributing causes of and ending the childhood chronic disease crisis.

Sec. 5.  Initial Assessment and Strategy from the Make America Healthy Again Commission.  (a)  Make our Children Healthy Again Assessment.  Within 100 days of the date of this order, the Commission shall submit to the President, through the Chair and the Executive Director, the Make Our Children Healthy Again Assessment, which shall:

(i)     identify and describe childhood chronic disease in America compared to other countries;

(ii)    assess the threat that potential over-utilization of medication, certain food ingredients, certain chemicals, and certain other exposures pose to children with respect to chronic inflammation or other established mechanisms of disease, using rigorous and transparent data, including international comparisons;

(iii)   assess the prevalence of and threat posed by the prescription of selective serotonin reuptake inhibitors, antipsychotics, mood stabilizers, stimulants, and weight-loss drugs;

(iv)    identify and report on best practices for preventing childhood health issues, including through proper nutrition and the promotion of healthy lifestyles;

(v)     evaluate the effectiveness of existing educational programs with regard to nutrition, physical activity, and mental health for children;

(vi)    identify and evaluate existing Federal programs and funding intended to prevent and treat childhood health issues for their scope and effectiveness;

(vii)   ensure transparency of all current data and unpublished analyses related to the childhood chronic disease crisis, consistent with applicable law;

(viii)  evaluate the effectiveness of current Federal Government childhood health data and metrics, including those from the Federal Interagency Forum on Child and Family Statistics and the National Survey of Children’s Health;

(ix)    restore the integrity of science, including by eliminating undue industry influence, releasing findings and underlying data to the maximum extent permitted under applicable law, and increasing methodological rigor; and

(x)     establish a framework for transparency and ethics review in industry-funded projects.

(b)  Make our Children Healthy Again Strategy.  Within 180 days of the date of this order, the Commission shall submit to the President, through the Chair and the Executive Director, a Make Our Children Healthy Again Strategy (Strategy), based on the findings from the Make Our Children Healthy Again Assessment described in subsection (a) of this section.  The Strategy shall address appropriately restructuring the Federal Government’s response to the childhood chronic disease crisis, including by ending Federal practices that exacerbate the health crisis or unsuccessfully attempt to address it, and by adding powerful new solutions that will end childhood chronic disease.

(c)  The Chair may hold public hearings, meetings, roundtables, and similar events, as appropriate, and may receive expert input from leaders in public health and Government accountability. 

Sec. 6.  Additional Reports.  (a)  Following the submission to the President of the Strategy, and any final strategy reports thereafter, the Chair and the Executive Director shall recommend to the President updates to the Commission’s mission, including desired reports.

(b)  The Commission shall not reconvene, following submission of the Strategy, until an updated mission is submitted to the President through the Executive Director.

Sec. 7.  General Provisions.  (a)  Nothing in this order shall be construed to impair or otherwise affect:

(i)   the authority granted by law to an executive department or agency, or the head thereof; or

(ii) las funciones del Director de la Oficina de Administración y Presupuesto relacionadas con propuestas presupuestarias, administrativas o legislativas.

(b) Esta orden se implementará de conformidad con la ley aplicable y sujeta a la disponibilidad de asignaciones.

(c) Esta orden no pretende, y no crea, ningún derecho o beneficio, sustantivo o procesal, exigible por ley o en equidad por ninguna de las partes contra los Estados Unidos, sus departamentos, agencias o entidades, sus funcionarios, empleados o agentes, o cualquier otra persona.

LA CASA BLANCA,

    13 de febrero de 2025.